Iranian National Formulary

A Pharmacy in Iranian city of Nishapur

The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council.

Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals. [1] Formalities for approval of a new molecule can take between 1 month and 12 months (maximum), as follows:

  1. 1 month: for new strength/dosage form of any registered/approved product;
  2. 3 to 7 months: for any new product to the INF list.

Top 20 drug molecules and sales in Iran

Top 20 molecules[2]
Molecule Sales for the first 6 month of 2010 (in Iranian Rials)
1INTERFERON423,996,630,000
2CEFIXIME 397,896,015,000
3AMOXICILLIN 323,624,414,264
4CO-AMOXICLAV 231,047,948,600
5ACETAMINOPHEN 210,953,849,492
6ALBUMIN 210,632,806,000
7DOCETAXEL 182,924,555,600
8IMIPENEM+CILASTATAIN 181,099,640,000
9CLOPIDOGREL 169,915,498,015
10IMMUNE GLOBULIN 160,575,717,000
11ENOXAPARIN 145,486,724,600
12CEFALEXIN 142,499,418,000
13DEXTROSE 141,272,434,000
14ATORVASTATIN 132,514,275,600
15PANTOPRAZOL 130,971,241,400
16SALMETEROL 127,780,028,000
17SODIUM CHLORIDE 126,043,613,100
18IBUPROFEN 125,621,562,500
19RITUXIMAB 118,690,006,000
20ERYTHROPOIETIN 110,191,720,000

See also

References

  1. ↑ https://web.archive.org/web/20070306004716/http://www.austrade.gov.au/Health-services-and-pharmaceuticals-to-Iran/default.aspx
  2. ↑ http://iran-pharma.blogspot.com/
This article is issued from Wikipedia - version of the 3/25/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.